UNC Lineberger Comprehensive Cancer Center: Multiple Myeloma trials

The registry lists 18 Multiple Myeloma studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 5 are open to participants now and 4 have results posted.

Phase 1 5Phase 2 8No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology ClinicsRecruitingNCT06296368Not applicable
• Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple MyelomaRecruitingNCT05145400Phase 2
• Registry for Adults With Plasma Cell Disorders (PCD's)RecruitingNCT03717844
• Registry of Older Patients With CancerRecruitingNCT01137825
• Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruitingNCT01137643
• Isa-Pom-Dex in Elderly/Frail Subjects With RRMMActive, not recruitingNCT05911321Phase 2Results posted
• Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple MyelomaCompletedNCT04999085Not applicableResults posted
• Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenCompletedNCT00448357Phase 1/2Results posted
• Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseCompletedNCT00448201Phase 2Results posted
• Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T CellsWithdrawnNCT07071909Phase 1/2
• Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell TransplantationWithdrawnNCT06348147Phase 2
• Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)TerminatedNCT05276622
• Financial Difficulty in Patients With Blood CancerCompletedNCT05212233
• Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple MyelomaActive, not recruitingNCT03672318Phase 1
• Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaWithdrawnNCT01492881Phase 2
• Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving ChemotherapyCompletedNCT01132833
• Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00744354Phase 1
• Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerCompletedNCT00237627Phase 1/2